Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.

International journal of molecular sciences - 14 Apr 2020

Olivera Gladys G, Yáñez Yania, Gargallo Pablo, Sendra Luis, Aliño Salvador F, Segura Vanessa, Sanz Miguel Ángel, Cañete Adela, Castel Victoria, Font De Mora Jaime, Hervás David, Berlanga Pablo, Herrero María José

Abstract excerpt

Single nucleotide polymorphisms (SNPs) in Pharmacogenetics can play an important role in the outcomes of the chemotherapy treatment in Neuroblastoma, helping doctors maximize efficacy and minimize toxicity. Employing AgenaBioscience MassArray, 96 SNPs were genotyped in 95 patients looking for associations of SNP with response to induction therapy (RIT) and grade 3-4 toxicities, in High Risk patients. Associations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to N-Myc Proto-Oncogene Protein

Share to Neuroblastoma

Share to Prognosis

Share to Receptors, Calcitriol

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 32295184
DOI: 10.3390/ijms21082714
PMCID: PMC7215604

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.PMID 32295184Read ↗

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?Semantic proximity Read ↗

Genetic variants of m1A modification genes and the risk of neuroblastoma: novel insights from a Chinese case-control study.Semantic proximity Read ↗

Identification of Mitochondrial DNA Variants Associated With Risk of Neuroblastoma.Semantic proximity Read ↗

Association of MALAT1 gene polymorphisms with neuroblastoma susceptibility in children from Jiangsu Province.Semantic proximity Read ↗

Association of TRDMT1 Gene Polymorphisms With Neuroblastoma Susceptibility: Insights From a Case-Control Study.Semantic proximity Read ↗

Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?Semantic proximity Read ↗

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.Semantic proximity Read ↗

Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma.Semantic proximity Read ↗

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.Semantic proximity Read ↗

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.Semantic proximity Read ↗

Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma.Semantic proximity Read ↗

Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.